Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Filing Names

University Of Zurich
University Of Zurich Prorektorat Forschung

University Of Zurich patents

Recent patent applications related to University Of Zurich. University Of Zurich is listed as an Agent/Assignee. Note: University Of Zurich may have other listings under different names/spellings. We're not affiliated with University Of Zurich, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "U" | University Of Zurich-related inventors

Recombinant human antibodies for therapy and prevention of polyomavirus-related diseases

Provided are novel human-derived antibodies specifically recognizing polyomavirus polypeptides, preferably capable of binding to polyomaviruses of the type of JC virus (JCV) and/or BK virus (BKV) as well as methods related thereto. Furthermore, assays and kits related to antibodies specific for polyomaviruses, polyomavirus VP1 and or polyomavirus VP1 Virus-Like Particles... University Of Zurich

Novel diagnostic and therapeutic target in inflammatory and/or cardiovascular diseases

Methods for diagnosing inflammatory and/or cardiovascular diseases by assaying for Fibroblast Activation Protein (FAP) expression in a body fluid is provided as well as therapeutic means based thereon.... University Of Zurich

Novel anti-fibroblast activation protein (fap) antibodies and uses derived thereof

Provided are novel human-derived antibodies specific for Fibroblast Activation Protein (FAP), preferably capable of selectively inhibiting the enzymatic activity of FAP, as well as methods related thereto. In addition, methods of diagnosing and/or monitoring diseases and treatments thereof which are associated with FAP are provided. Assays and kits related to... University Of Zurich

Method of providing disease-specific binding molecules and targets

Provided are novel specific binding molecules, particularly human antibodies as well as fragments, derivatives and variants thereof that recognize neoepitopes of disease-associated proteins which derive from native endogenous proteins but are prevalent in the body of a patient in a variant form and/or out of their normal physiological context. In... University Of Zurich

Benzazepin-1-ol-derived pet ligands with high in vivo nmda specificity

The present invention is directed to benzazepin-1-ol-derived compounds for use in the diagnosis of NMDA receptor-associated diseases or disorders by positron emission tomography (PET). The invention also relates to a method for the diagnosis of NMDA-receptor-associated diseases or disorders by administering to a patient in need of such diagnosis a... University Of Zurich

Tdp-43 specific binding molecules

Provided are novel TDP-43-specific binding molecules including polypeptides such as human antibodies, as well as fragments, derivatives and variants thereof. Also provided are methods related to these TDP-43 specific binding molecules. Assays, kits, and solid supports related to TDP-43-specific binding molecules, including polypeptides such as, human antibodies are also disclosed.... University Of Zurich

Carbon monoxide releasing rhenium compounds for medical use

with medical utility, corresponding pharmaceutical compositions as well as medical uses thereof.... University Of Zurich

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with University Of Zurich in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for University Of Zurich with additional patents listed. Browse our Agent directory for other possible listings. Page by